Amphastar Pharmaceuticals jumps 10 percent this week, though earnings growth is still tracking behind three-year shareholder returns
AMPH Stock | USD 41.33 0.49 1.20% |
Under 61% of all Amphastar's traders are looking to take a long position. The analysis of overall sentiment of trading Amphastar P stock suggests that some investors are interested at this time. Amphastar's investing sentiment shows overall attitude of investors towards Amphastar P.
Amphastar |
The most you can lose on any stock is 100 percent of your money. But when you pick a company...
Read at finance.yahoo.com
Amphastar Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Amphastar can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Amphastar Fundamental Analysis
We analyze Amphastar's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amphastar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amphastar based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Amphastar is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Amphastar P Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amphastar stock to make a market-neutral strategy. Peer analysis of Amphastar could also be used in its relative valuation, which is a method of valuing Amphastar by comparing valuation metrics with similar companies.
Peers
Amphastar Related Equities
NBIX | Neurocrine Biosciences | 1.27 | ||||
SUPN | Supernus Pharmaceuticals | 0.88 | ||||
COLL | Collegium Pharmaceutical | 0.78 | ||||
IRWD | Ironwood Pharmaceuticals | 0.28 | ||||
ALKS | Alkermes Plc | 0.07 | ||||
PCRX | Pacira BioSciences, | 0.10 | ||||
EOLS | Evolus | 0.60 | ||||
PBH | Prestige Brand | 0.87 | ||||
ANIP | ANI Pharmaceuticals | 0.99 | ||||
PAHC | Phibro Animal | 1.24 | ||||
EVO | Evotec SE | 2.81 |
Complementary Tools for Amphastar Stock analysis
When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |